These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 26250458
1. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas. Yan J, Zhang Y, Shi W, Ren C, Liu Y, Pan Y. Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458 [Abstract] [Full Text] [Related]
2. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer. Shi Z, Li X, Wu D, Tang R, Chen R, Xue S, Sun X. Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800 [Abstract] [Full Text] [Related]
3. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T. Cancer Lett; 2014 Dec 01; 355(1):130-40. PubMed ID: 25218351 [Abstract] [Full Text] [Related]
4. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. Zhao XP, Zhang H, Jiao JY, Tang DX, Wu YL, Pan CB. J Transl Med; 2016 Jan 27; 14():26. PubMed ID: 26818837 [Abstract] [Full Text] [Related]
6. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition. Han W, Zhang Y, Niu C, Guo J, Li J, Wei X, Jia M, Zhi X, Yao L, Meng D. Cancer Lett; 2019 Mar 31; 445():45-56. PubMed ID: 30654010 [Abstract] [Full Text] [Related]
7. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2. Xing F, Song Z, He Y. Biol Res; 2018 Nov 24; 51(1):50. PubMed ID: 30474570 [Abstract] [Full Text] [Related]
8. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway. Ping H, Guo L, Xi J, Wang D. Tumour Biol; 2017 Jun 24; 39(6):1010428317713389. PubMed ID: 28651497 [Abstract] [Full Text] [Related]
9. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. Zhang H, Tang Z, Deng C, He Y, Wu F, Liu O, Hu C. Oral Dis; 2017 Mar 24; 23(2):255-264. PubMed ID: 27809392 [Abstract] [Full Text] [Related]
10. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. Lee J, Ha S, Jung CK, Lee HH. Int J Oncol; 2015 Mar 24; 46(6):2431-8. PubMed ID: 25845850 [Abstract] [Full Text] [Related]
11. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells. Shi Z, Wu D, Tang R, Li X, Chen R, Xue S, Zhang C, Sun X. J Biosci; 2016 Jun 24; 41(2):229-36. PubMed ID: 27240983 [Abstract] [Full Text] [Related]
12. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Law AY, Wong CK. Exp Cell Res; 2010 Dec 10; 316(20):3425-34. PubMed ID: 20619259 [Abstract] [Full Text] [Related]
13. High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diffuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2). Wang Y, Tan J, Wu H, Yi C. Med Sci Monit; 2019 May 24; 25():3860-3868. PubMed ID: 31124542 [Abstract] [Full Text] [Related]
18. Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells. Xi YN, Xin XY, Ye HM. Asian Pac J Trop Med; 2014 Apr 24; 7(4):289-92. PubMed ID: 24507678 [Abstract] [Full Text] [Related]